Enliven Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $303k | 22k | 13.84 |
| 2023-09-30 | $312k | 23k | 13.66 |
| 2023-06-30 | $491k | 24k | 20.41 |